Cancer Types
CANCER TYPES
Breast Cancer
Abemaciclib Plus Endocrine Therapy Deemed Beneficial in High-Risk Early Breast Cancer After Neoadjuvant Chemo
The combination improved invasive disease-free survival and distant relapse-free survival.
Most Patients With Metastatic Breast Cancer Favor Personalized Drug Dose Options to Minimize Adverse Effects
Results of an online survey evaluating the experiences and preferences of patients with metastatic breast cancer were reported.
Cervical Cancer
Lack of Standardized Screening Linked to Increased Incidence of Many HPV-Related Cancers
For HPV-related cancers without standardized screening, incidence rates increased between 2001 and 2017.
Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer
Tisotumab vedotin is an investigational antibody-drug conjugate targeted to tissue factor.
Colorectal Cancer
Family History of Polyps Raises Colorectal Cancer Risk
Having a first-degree relative with colorectal polyps may increase a person’s risk of developing colorectal cancer, indicating that earlier screening is warranted.
Pembrolizumab May Improve Health-Related Quality of Life in Metastatic Colorectal Cancer
Health-related quality of life tended to improve over time with pembrolizumab but not with chemotherapy.
Gastrointestinal Cancer
High Body Mass Index Is a Risk Factor for Gallbladder and Biliary Tract Cancer Mortality
Outcomes of Readmissions Following HPB or Gastric Cancer Compared Between Index, Outside Hospitals
Genitourinary Cancer
Chronic Kidney Disease Is More Common in the Cancer Population
Delaying Surgical Intervention Not Likely to Increase Mortality in Patients With Metastatic Renal Cell Carcinoma
Gynecologic Cancer
Secondary Cytoreduction Improves Progression-Free Survival in Platinum-Sensitive, Relapsed Ovarian Cancer
PARP Inhibitor Maintenance Improves PFS in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer
Leukemia
Tisagenlecleucel Appears Effective in Babies With Advanced B-Cell Acute Lymphoblastic Leukemia
GAB1 Inhibitors Show Promise as Treatment Option for Chronic Lymphocytic Leukemia
Liver Cancer
Rurality, Income Impact Stage at Diagnosis, Mortality in Liver Cancer
FDA Denies Accelerated Approval of Keytruda Plus Lenvima for Unresectable HCC
Lung Cancer
Delay in Surgical Intervention for Early-Stage Non-Small Cell Lung Cancer Increases Risk for Recurrence
Less Pain, Fewer Complications With VATS vs Open Surgery in Early-Stage Lung Cancer
Lymphoma
Survival Rates for Allogeneic, Autologous HSCT Are Similar in Patients With R/R Peripheral T-Cell Lymphoma
Model May Identify Non-ETP T-ALL Patients at High Risk of Poor Response to Treatment
Melanoma
Neoadjuvant Nivolumab Plus Relatlimab Produced a High pCR Rate in Stage III-IV Melanoma
Adjuvant Pembrolizumab Improves RFS, Not OS, in Resected High-Risk Melanoma
Multiple Myeloma
Combination Therapy Shows Promise in Patients With Ultra High-Risk Multiple Myeloma, PCL
Phase 3 Trial Evaluating Venetoclax, Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes
Ovarian Cancer
Study Reports Improved Outcomes With Olaparib Maintenance in Ovarian Cancer
Most Patients With Breast, Ovarian Cancer Do Not Undergo Genetic Testing
Pancreatic Cancer
Mutational Risk Not Associated With Distant Metastasis in Medullary Thyroid Cancer
Cabozantinib Gets Breakthrough Tx Status for Differentiated Thyroid Cancer
Prostate Cancer
TAK-700 Improves PFS, Not OS, Compared With Bicalutamide in Metastatic Hormone-Sensitive Prostate Cancer
Genomic Landscape of Prostate Cancer Differs by Ancestry, but Frequency of Actionable Alterations Is Similar
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...